Risk factors for pregnancy-associated heart failure with preserved ejection fraction and adverse pregnancy outcomes: a cross-sectional study
Abstract Background Although pregnancy-associated heart failure with preserved ejection fraction (HFpEF) is increasing and contributing to maternal morbidity, little is known about its impact on pregnancy. We examined the risk factors for and adverse pregnancy outcomes of HFpEF in pregnant women. Methods We conducted a cross-sectional analysis of pregnancy-related hospitalizations from 2009 to 2020 using the perinatal database of seven multicenters. Cases of HFpEF were identifed using the International Classifcation of Diseases and echocardiography fndings. The patients were categorized into the HFpEF and control groups. Risk factors were evaluated using multivariate logistic regression analysis to generate odds ratios (OR) and 95% confdence intervals (CI). Furthermore, adjusted associations between HFpEF and adverse pregnancy outcomes were determined. Risk scores for the stratifcation of women at a high risk of HFpEF were calculated using a statistical scoring model. Results Of the 34,392 women identifed, 258 (0.76%) were included in the HFpEF group. In multivariate analysis, HFpEF was signifcantly associated with old maternal age (OR, 1.04; 95% CI 1.02–1.07), multiple pregnancy (OR, 2.22; 95% CI 1.53–3.23), rheumatic disease (OR, 2.56; 95% CI 1.54–4.26), pregnancy induce hypertension (OR 6.02; 95% CI 3.61–10.05), preeclampsia (OR 24.66; 95% CI 18.61–32.66), eclampsia or superimposed preeclampsia (OR 32.74; 95% CI 21.60–49.64) and transfusion in previous pregnancy (OR 3.89; 95% CI 1.89–8.01). A scoring model to predict HFpEF with those factors achieved an area under the curve of 0.78 at cutof value of 3. Women with HFpEF also had increased odds ratios of intensive care unit admission during the perinatal period (odds ratio, 5.98; 95% confdence interval, 4.36–8.21) and of postpartum hemorrhage (odds ratio, 5.98; 95% confdence interval, 2.02–3.64). Conclusions Pregnancy-associated HFpEF is associated with adverse pregnancy outcomes. A scoring model may contribute to screening HFpEF using echocardiography and preparing adverse pregnancy outcomes.
درمان نازایی با روش IVF
روش IVF مخفف (In Vitro Fertilization) یا لقاح خارج از رحم، یکی از روشهای درمان نازایی است. در این روش، تخمکها از تخمدان خارج شده و در آزمایشگاه با اسپرم بارور میشوند. این روش اصولا برای افرادی مناسب است که از مشکلاتی مانند چسبندگی لولههای رحم یا مسدود بودن لولههای فالوپ رنج میبرند.